학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 876건 | 목록 1~20
Academic Journal
Skoulidis F; Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, United States.; Li BT; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, United States.; Hochmair M; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, 1210 Vienna, Austria.; Govindan R; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States.; Vincent M; London Health Sciences Centre, Victoria Hospital, London, ON N6A 5W9, Canada.; van der Wekken AJ; Department of Pulmonary Diseases and Tuberculosis, University Medical Center Groningen, University of Groningen, 9713 GZ Groningen, the Netherlands.; Reguart Aransay N; Medical Oncology Department, Thoracic Oncology Unit Hospital Clinic, IDIBAPS, University of Barcelona, Villarroel, 08036 Barcelona, Spain.; O'Byrne KJ; Faculty of Health, Queensland University of Technology, Brisbane, QLD 4000, Australia.; Girard N; Institut du Thorax Curie-Montsouris, Institut Curie, 75014 Paris, France.; Griesinger F; Pius-Hospital Oldenburg, Department of Haematology and Oncology, University Department Internal Medicine-Oncology, University Medicine Oldenburg, 26121 Oldenburg, Germany.; Nishio M; Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan.; Häfliger S; Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.; Lindsay C; Division of Cancer Sciences, University of Manchester, Manchester M13 9PL, United Kingdom.; The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom.; Reinmuth N; Department of Oncology, Asklepios Lung Clinic, German Center for Lung Research, Munich-Gauting, 82131 Gauting, Germany.; Paulus A; Department of Respiratory Medicine, University Hospital (CHU) of Liège, 4000 Liège, Belgium.; Papakotoulas P; First Department of Clinical Oncology, Theageneio Cancer Hospital, 54639 Thessaloniki, Macedonia, Greece.; Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.; Ferreira CG; Oncoclinicas, Rio De Janeiro, RJ, 22251-060, Brazil.; Pasello G; Dipartimento di Scienze Chirurgiche, Oncologichee Gastroenterologiche (DiSCOG) dell'Università di Padova, Oncologia 2, Istituto Oncologico Veneto IRCCS, 64 Padova, Italy.; Duruisseaux M; Department of Medical Oncology, CHU de Lyon - Hôpital Lyon Sud, 69495 Lyon, France.; Gennatas S; Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London SE1 7EH, United Kingdom.; Dimou A; Department of Oncology, Mayo Clinic, Rochester, MN 55905, United States.; Mehta B; Amgen Inc., Thousand Oaks, CA 91320, United States.; Kormany W; Amgen Inc., Thousand Oaks, CA 91320, United States.; Nduka C; Amgen Inc., Thousand Oaks, CA 91320, United States.; Sylvester BE; Amgen Inc., Thousand Oaks, CA 91320, United States.; Ardito-Abraham C; Amgen Inc., Thousand Oaks, CA 91320, United States.; Wang Y; Amgen Inc., Thousand Oaks, CA 91320, United States.; de Langen AJ; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Thoracic Oncology, 1066 CX Amsterdam, The Netherlands.
Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE
Academic Journal
Mineeva O; Department of Computer Science, ETH Zurich, Zurich, Switzerland; Max Planck Institute for Intelligent Systems, Tuebingen, Germany.; Li C; Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham & Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.; Giulianini F; Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham & Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.; Häfliger S; Department of Computer Science, ETH Zurich, Zurich, Switzerland.; Bubes V; Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham & Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.; Raetsch G; Department of Computer Science, ETH Zurich, Zurich, Switzerland.; Mora S; Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham & Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA; Cardiovascular Medicine Division, Mass General Brigham, Boston, Massachusetts, USA. Electronic address: smora@bwh.harvard.edu.; Demler OV; Department of Computer Science, ETH Zurich, Zurich, Switzerland; Center for Lipid Metabolomics, Division of Preventive Medicine, Brigham & Women's Hospital, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.
Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918419284106676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2772-963X (Electronic) Linking ISSN: 2772963X NLM ISO Abbreviation: JACC Adv Subsets: PubMed not MEDLINE
Academic Journal
Paulson KG; Center for Immuno-Oncology, Paul G Allen Research Center, Department of Medical Oncology, Providence-Swedish Cancer Institute, Seattle, WA, USA. Electronic address: kelly.paulson@providence.org.; Lau SCM; Department of Medicine, Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY, USA.; Ahn MJ; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Moskovitz M; Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.; Pogorzelski M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, Essen, Germany.; Häfliger S; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.; Parkes A; Early Development, Amgen, Thousand Oaks, CA, USA.; Zhang Y; Global Biostatistics, Amgen, Thousand Oaks, CA, USA.; Hamidi A; Global Safety, Amgen, Thousand Oaks, CA, USA.; Thompson CG; Clinical Pharmacology Modeling and Simulation, Amgen, Thousand Oaks, CA, USA.; Wermke M; TU Dresden, NCT/UCC Early Clinical Trial Unit and Medical Clinic and Poliklinik I, Dresden, Germany.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Häfliger, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어